Clinical Trial Update: Epidemiological Study of Treatment Approaches in AChR-Antibody Positive Generalized Myasthenia Gravis in Russia

View source ↗

Summary

AstraZeneca is sponsoring an epidemiological study in Russia on treatment approaches for AChR-antibody positive generalized myasthenia gravis (gMG). The study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Myasthenia Gravis

Snippet

Sponsor: AstraZeneca | Conditions: Rare Diseases, Generalized Myasthenia Gravis (gMG) | Status: RECRUITING